Russia strikes the world: 91.6 percent efficiency in Sputnik V vaccine for Covid-19 symptoms

Russian vaccine Sputnik V has resulted in 91.6 per cent effective countering symptoms of coronarys, has discovered an internal test. Initial findings are based on analysis of data by more than 20,000 participants. Three quarters of these people had received the vaccine in question, and the rest placebo. Nothing unpleasant [...]
Initial findings are based on analysis of data by more than 20,000 participants. Three quarters of these people had received the vaccine in question, and the rest placebo.
Nothing unpleasant was related to the vaccine, since most had reported light side effects, including flulike symptoms, writes The Guardian, followed Periscope.
The vaccine, which is supported by the Russian Direct Investment Fund. [ Footnote] RDIF is administered in two separate injections for 21 days. 21 days after the first dose, there were 16 cases of Covid-19 out of 14 thousand and 964 in the group of participants who had taken the vaccine, and 62 cases of 4902 of those who had taken placebon.
Tests included 2144 participants aged 60 and higher; in this subgroup, vaccine was effective 91.8 percent against symptoms.












